Fri, Apr 18, 2014, 9:12 PM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • kootloops kootloops May 23, 2013 9:27 PM Flag

    Things to know about ALIM

    1. Preliminary sales data from the EU should be out by mid June
    -if sales are good the stock price should test $5.10 area and push through
    -if sales are bad... most likely will test $3.40 area
    -if sales are average .. most likely up to $4.80 area
    2. ALIM will triple from here is approved in the US
    -One thing to note is: that if approved in the US they will owe PSDV $25million cash. They will need to dilute to pay PSDV. I believe they will annouce dilution within 1 or 2 days of FDA approval. At the end of Q1 they only had 39 Million cash/equiv +20million atm. I dont think they will sell themselves short and dilute before FDA approval.
    3. Continued european expansion into Q3, Q4 and 2013. Positive share price appreciation.
    4. If a big pharma is going to buy them out they are also going to make a bid for PSDV. WIth the royalty set up there is no point of buying one without the other. They are both cheap enough to do so.
    5. There are others but they can wait.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • BUMP!

      May retest $3.40 before going on a tear into PDUFA date. I am buyer below $4!

    • Is Yahoo correct that there is only 3M in the float??

    • ddeboy@sbcglobal.net ddeboy May 28, 2013 10:03 AM Flag

      Hey Koot-
      What about if the FDA passes the diabetic shot? I see this as 12 at least.

    • Sales out by mid June? Would this be sales through May? Who would be reporting these sales figures? Alimera? Doubt that. I don't see sales as highly relevant at this point anyway since they do not have reimbursement agreements in place with the big insurers in Germany yet and they are still waiting to hear from the NICE commission in the UK on government reimbursement. Govt. reimbursement in the UK is worth 85% of the UK market.

      IMO if you believe the device will obtain govt approval in the UK and approval in the US later in the year you should hold on to your investment and not attempt to guess the short term fluctuations.

      btw, my advice to you is that you shouldn't write an investor column in seeking alpha then conduct yourself in other forums like a day trader. Your credibility with me and I'm sure plenty of others is shot.

    • trollen32@sbcglobal.net trollen32 May 24, 2013 9:51 AM Flag

      koot, Somehow I see phizer in the mix for a lock stock and barrel head for Alim/.psdv.,as a one/two aqui.........It's a good fit..............If you consider the delivery sys and it's versatility in the psdv pipeline..........What a pickoff......luck...tro

 
ALIM
6.31+0.01(+0.16%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
Fifth Third Bancorp
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT